FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
GlobalData on MSN
FDA approves J&J’s TECNIS PureSee intraocular lens
The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.
Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
Johnson & Johnson (JNJ) wins FDA approval for Tecnis PureSee intraocular lens ((IOL)), giving eye surgeons a new lens option for use in cataract surgery. Read more here.
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this Healio Video Perspective from the AAO meeting, Daniel H. Chang, MD, of Empire Eye and Laser ...
ClearSight is now offering the Tecnis Odyssey Lens, a next-generation intraocular lens (IOL) designed for patients undergoing cataract surgery or Custom Lens Replacement. This advanced lens technology ...
Launched in the month of World Sight Day, this next-generation monofocal intraocular lens is an advanced solution for post cataract surgery patients, that helps to meet the changing lifestyle needs of ...
ABBOTT PARK, Ill., April 18, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the TECNIS ® Toric 1-Piece intraocular lens (IOL) has received U.S. Food and Drug Administration (FDA) ...
Traditional monofocal IOLs have been limited to improving distance vision. The Tecnis Symfony IOL improves visual acuity at close, intermediate and far ranges and, therefore, may reduce the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results